FAIRLY VALUED
HONGSENG 0041
| PREV | CLOSE | CHANGE | HIGH | CLOSE |
|---|---|---|---|---|
| 1.000 | 1.000 | - | 1.020 | 0.995 |
| VOLUME | BUY VOL | BUY | SELL | SELL VOL |
|---|---|---|---|---|
| 71,374 | 15,607 | 0.995 | 1.000 | 287 |
52 Weeks Range : 0.04 - 1.88
3.4/10
(Expert Score)
Stock is rated as #65 in category BM Technology
Fairly Valued. Reach or higher than intrinsic value.
PROS:
- Positive Cash Company
- Very Low Gearing
- Very High Trading Value
CONS:
- Making Huge Loss
- No Dividend Declared
- Very Low Price-to-Tangible
klse: Hong Seng Consolidated Berhad
Corporate Information
Board : Main
Shariah : Shariah Compliant
Sector : Information Technology Services
Packaged Software
Address: Gate C, 2nd Floor No 3, Jalan TP 2 Taman Perindustrian UEP 47600 Subang Jaya
Contact: +603-7890 3535
Website: https://hongseng.com.my
Corporate Background
Hong Seng Consolidated Berhad, (formerly named as MSCM Holdings Berhad/CBS Technology Berhad), an investment holding company, provides radio frequency identification (RFID), e-security, supply chain management, and enterprise productivity solutions in Malaysia
Forecast: HONGSENG 0041
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 21/08/20 | 528 | -1 | -1 |
| 18/06/20 | 337 | -8,241 | -8,216 |
| 27/02/20 | 749 | -579 | -574 |
| 28/11/19 | 1,323 | 951 | 943 |
| 30/08/19 | 2,021 | 412 | 412 |
| 30/05/19 | 983 | -7,552 | -8,070 |
| 25/02/19 | 3,989 | -6,183 | -6,125 |
| 21/11/18 | 2,723 | 250 | 250 |
| 29/08/18 | 2,813 | 861 | 873 |
| 31/05/18 | 5,988 | -19,400 | -20,904 |
| 27/02/18 | 12,023 | -578 | -742 |
| 23/11/17 | 5,048 | -3,831 | -3,620 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 2,937 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | -7,848 |
| Last 4 Quarter EPS (sen) | -2.4 |
| Last 4 Quarter PER | – |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | – |
| Net Tangible Assets (RM) | 0.19 |
| Goodwill (RM) | 0 |
| Cash (RM’000) | 53,150 |
| Debt (RM’000) | 1,910 |
| Total Debt (RM’000) | 4,030 |
| Net Assets (RM’000) | 61,330 |
| Current Ratio | 16.24 |
| Quick Ratio | 16.24 |
| Cash Ratio | 15.89 |
Technical
Technical Analysis
| MACD (26 vs 12) | -0.006 |
|---|---|
| Exponential Moving Average 5 | 1.025 |
| Exponential Moving Average 20 | 1.04 |
| Exponential Moving Average 90 | 0.811 |
| Relative Strength Index 14 | 0.48 |
| Stochastic %D 3 | 0.12 |
| Stochastic %K 14 | 0.03 |
1 review for HONGSENG 0041
Show all
Most Helpful
Highest Rating
Lowest Rating
Add a review
HONGSENG 0041
| PREV | CLOSE | CHANGE | HIGH | CLOSE |
|---|---|---|---|---|
| 1.000 | 1.000 | - | 1.020 | 0.995 |
| VOLUME | BUY VOL | BUY | SELL | SELL VOL |
|---|---|---|---|---|
| 71,374 | 15,607 | 0.995 | 1.000 | 287 |
The Star –
Hong Seng Consolidated Bhd, via its wholly-owned subsidiary HS Bio Supplies Sdn Bhd, has acquired 51% stake in Pantasniaga Sdn Bhd, which has been supplying polymerase chain reaction (PCR) test kits for Covid-19. As Pantasniaga has already performed and fulfilled a few supply contracts for Malaysian government agencies, Hong Seng said HS Bio would be continuing its support to procure and supply the PCR test kits with the ongoing outbreak in Malaysia, as well as neighbouring countries.